Panacea Biotec Ltd.

DUBLIN--( BUSINESS WIRE )--The "Bioengineered Protein Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Bioengineered Protein Drugs is estimated at US$245.5 Billion in 2023 and is projected to reach US$329.9 Billion by 2030, growing at a CAGR of 4.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The growth in the bioengineered protein drugs market is driven by several factors, including technological advancements, increased prevalence of chronic diseases, and growing acceptance and demand for personalized medicine. Technological innovations have streamlined the drug development process, reducing costs and time-to-market, while biopharmaceutical companies are leveraging these advancements to develop more potent and targeted therapies. The rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has also heightened the demand for these advanced treatments. Furthermore, consumer behavior trends indicate a strong preference for personalized medicine, which bioengineered proteins are uniquely positioned to deliver due to their ability to be tailored to individual genetic profiles. Additionally, favorable regulatory policies and increased healthcare funding in many regions are supporting the rapid market expansion. Investment in research and development by both private and public sectors is also pivotal, driving continuous innovation and the introduction of next-generation biopharmaceuticals. Key Insights: Market Growth: Understand the significant growth trajectory of the Therapeutic Proteins segment, which is expected to reach US$129.2 Billion by 2030 with a CAGR of a 3.9%. The Monoclonal Antibodies segment is also set to grow at 4.3% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, estimated at $66.2 Billion in 2023, and China, forecasted to grow at an impressive 7.2% CAGR to reach $69.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of major players such as Abbott India Ltd., Amgen, Inc., Bayer AG, and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Key Attributes: Report Attribute Details No. of Pages 193 Forecast Period 2023 - 2030 Estimated Market Value (USD) in 2023 $245.5 Billion Forecasted Market Value (USD) by 2030 $329.9 Billion Compound Annual Growth Rate 4.3% Regions Covered Global Key Topics Covered: MARKET OVERVIEW Influencer Market Insights Global Economic Update Bioengineered Protein Drugs - Global Key Competitors Percentage Market Share in 2024 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E) MARKET TRENDS & DRIVERS Advances in Genetic Engineering Propel Growth in Bioengineered Protein Drugs Market Increasing Prevalence of Chronic Diseases Expands Addressable Market Opportunity Personalized Medicine Trends Strengthen Business Case for Bioengineered Proteins Innovations in Bioprocessing Technologies Drive Cost-Efficiency and Scalability Rising Consumer Demand for Targeted Therapies Generates Opportunities Adoption of CRISPR and Gene-Editing Tools Accelerates Development Timelines Healthcare Funding Increases Propel Market Adoption Enhanced Purification Techniques Improve Drug Safety and Efficacy Advanced Manufacturing Technologies Enhance Production Capabilities Post-Marketing Surveillance Strengthens Confidence in Bioengineered Protein Drugs Technological Synergies with Digital Health Tools Enhance Treatment Outcomes Novel Drug Delivery Systems Expand Therapeutic Applications Data Analytics and AI Integration Improve Drug Development Efficiency FOCUS ON SELECT PLAYERS (Total 56 Featured) Abbott India Ltd. Amgen, Inc. Bayer AG Biocon Ltd. Dr. Reddy's Laboratories Ltd. Eli Lilly and Company F. Hoffmann-La Roche AG GlaxoSmithKline PLC Johnson & Johnson Merck & Co., Inc. Novartis International AG Panacea Biotec Ltd. ProBioGen AG For more information about this report visit https://www.researchandmarkets.com/r/gyluz6 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

DUBLIN, Feb. 8, 2024 /PRNewswire/ -- The "Global Markets for Vaccine Technologies" report has been added to ResearchAndMarkets.com's offering. Advancements will occur in regard to the development of novel vaccines towards emerging infectious diseases, cancers and allergies. Continuous improvements in vaccine design, delivery technologies and manufacturing will also boost market growth. The global vaccine technologies market is segmented in this report by technology, disease, age, and region. This report explains critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors and provides insights to stakeholders and potential entrants. This report includes only human vaccines; animal vaccines have not been considered in this report. This study looks at research and development (R&D) spending, increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth. Company mergers, acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type, considering new technologies, growing competition and changing customer needs. The market has been analyzed based on the application of current vaccines. Categories considered in this report include pneumococcal vaccines; diphtheria, tetanus vaccines; HPV vaccines; MMR vaccines; and other vaccines including rotavirus vaccines, influenza vaccines, hepatitis B vaccines, chickenpox vaccines, polio vaccines, BCG, and yellow fever vaccines. This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories, various hospital settings, and pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest. This report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding geographic reach will also find this study useful. The Report Includes 34 data tables and 63 additional tables An up-to-date overview of the global markets for vaccine technologies Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028 Estimate of the market size and revenue forecast for the global market, and a corresponding market share analysis based on technology, disease indication, age group and region Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies, global R&D spending, and the regulatory landscape Assessment of present and future strategies in the innovation-driven vaccine technologies market, and a look at the vaccines for humans and their immunization schedule Discussion of the importance of ESG in the market for vaccine technologies, including consumer attitudes, the impact of ESG factors on company performance, and ESG practices of leading companies Review of patents and patent applications Overview of the major vendors, along with an analysis of the industry structure, including company market shares, recent M&A activity, and venture funding Analysis of the competitive landscape based on recent developments and segmental revenues Profiles of the leading companies Key Topics Covered: Chapter 1 Introduction Chapter 2 Summary and Highlights Chapter 3 Market and Technology Background Immune System and Vaccines Components of the Immune System Cells of the Immune System Immune Response Major Histocompatibility Complex (MHC) Immunization and Vaccines Disorders of the Immune System Impact of Lifestyle on the Immune System How Vaccines Work Principles of Immunization Types of Immunity Advantages of Vaccination History of Vaccines Vaccines and Immunization, Overview Types of Vaccines Attenuated (Live) Vaccines Inactivated (Killed) Vaccines Toxoid Vaccines Subunit Vaccines Conjugate Vaccines Recombinant Vector Vaccines DNA Vaccines RNA Vaccines Immunization Advantages of Immunization Adjuvants and Excipients Pathogen Components Particulate Adjuvants Infectious Diseases Preventable by Vaccine Human Diseases Viral Diseases Bacterial Diseases Regulatory Aspects World Health Organization (WHO) Prequalified Vaccines New Product Approvals Recalls Significant Regulatory Developments in Vaccines Chapter 4 Market Dynamics Market Drivers Growing Awareness of Immunization Growing Investments and R&D New Vaccines Prevalence of Infectious Diseases Market Restraints Vaccine Development and Pricing Market Opportunities Increased Demand from Emerging Markets Therapeutic Vaccines Chapter 5 Global Market for COVID-19 Vaccines COVID-19 Vaccine Technologies Advent of mRNA Technology Impact of COVID-19 on Routine Infant Vaccination COVID-19 Disruptions Stagnating Global Coverage Rate Progress and Challenges by Country and Region Chapter 6 Market Breakdown by Technology Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines Live-Attenuated Vaccines Inactivated Vaccines Toxoid Vaccines Other/Combination Vaccines Chapter 7 Market Breakdown by Disease Pneumococcal Diphtheria and Tetanus HPV MMR Chapter 8 Market Breakdown by Age Group Pediatrics Adolescents and Adults Chapter 9 Market Breakdown by Region Chapter 10 Emerging Technologies and Developments Developments mRNA Vaccines Viral Vector Vaccines Nanoparticle Vaccines DNA Vaccines Virus-Like Particle (VLP) Vaccines Self-Amplifying RNA Vaccines Innovative Adjuvants AI and Computational Biology Personalized Vaccines Plant-Based Vaccines Chapter 11 Competitive Landscape Chapter 12 Company Profiles Abbott Astrazeneca Bavarian Nordic Bharat Biotech International Emergent Biosolutions GSK Johnson & Johnson Services Merck Mitsubishi Tanabe Pharma Corp. Panacea Biotec Pfizer Inc. Sanofi For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

Yellow fever is essentially a mosquito-borne disease, which is more prevalent in African countries as well as in Central and South American region. Often, these diseases are transmitted across the countries via infected travelers, but it is more frequent in countries wherein the mosquito species are able to flourish in a region’s specific climatic conditions and the animal pool required to maintain their prosperity. In 2017, Brazil has notified more than half a dozen separate cases of yellow fever across the country and its prevalence continues to mount in different parts of the world too. As a result, the demand in the global yellow fever treatment market is expected to expand at a steady rate during the forecast period of 2017 to 2025. Factors such as unhygienic lifestyle, increasing awareness among people pertaining to the availability of the treatment to cure yellow fever, improving healthcare infrastructure in several emerging economies, growing number of international travelers, and increased efforts from health organizations such as the UNICEF and the World Health Organization (WHO) are some of the factors augmenting the demand in the global yellow fever treatment market. UNICEF already procures nearly 34 million yellow fever vaccination doses per year and has long-term agreements with four drug companies to provide the vaccination required for routine programmers, emergency, and preventive campaigns. Still, the supply is significantly insufficient to meet the increasing demand, and hence the demand in the global yellow fever treatment market is expected to swell consistently over the course of next few years. GET BROCHURE OF THE REPORT Global Yellow Fever Treatment Market: Overview Yellow fever is caused by a virus transferred through infected Aedes aegypti mosquitoes. These mosquitoes thrive near human dwellings and breed in clean waters. The occurrence of yellow fever is more prevalent in sub-Saharan Africa and tropical South America. Humans and monkeys represent the target patient population infected with yellow fever virus. Yellow fever infection can be lethal as it damages the liver and other internal organs. As per statistics of the World Health Organization, yellow fever affects more than 200,000 individuals every year, of which 90% are reported in Africa. These cases result in 30,000 deaths every year. Factors such as decreasing immunity among the local population, deforestation, and high-density urbanization increases the risk of yellow fever across the world. The report represents facts and figures pertaining to the global yellow fever treatment market in a chronological order. With a scrutiny of past data and current market trends, analysts present a satisfactory picture regarding the market’s future. The users of the report, therefore, receive accurate projections of the global yellow fever treatment market that can be used to formulate cutting-edge business strategies for the future. Using validated analytical tools such as Porter’s Five Forces analysis and SWOT analysis, the report presents valuable insights about the strengths, weakness, opportunities, and threats of the market until the end of the forecast period in 2025. A detailed analysis of the current competitive landscape is included in the report. The section includes a competitive pro the leading players and an analysis of their strengths, weakness, opportunities, and threats for the 2017-2025 period. GET TABLE OF CONTENT OF THE REPORT Global Yellow Fever Treatment Market: Disease Prevention Measures The prevention of yellow fever is essential and vaccination is advised for children above 9 months of age. These vaccines are usually administered by travel medicine clinics and local or state health departments and needs to be repeated every 10 years for individuals who travel frequently to high risk African and Latin American countries. Individuals with compromised immune system or cancer patient, pregnant women, and children below 9 months of age are recommended not to take yellow fever vaccine. Global Yellow Fever Treatment Market: Drivers and Restraints The increasing importance of travel medicine complemented by increasing involvement of respective governments for timely vaccination are the major factors driving the global yellow fever treatment market. However, factors such as demand-supply gap of vaccines and high costs are restraining the growth of this market. As per data provided by the United Nations International Children’s Emergency Fund (UNICEF), there is a large demand-supply gap for yellow fever vaccines. For instance, the demand exceeded supply by almost 44% for the year 2014-2015 despite procurement of all available vaccines by UNICEF. DiTu, LCTA-949, YF-17D, Flaviviruses infection vaccines represent some of the drugs under clinical trials for yellow fever. Major Companies Mentioned in Report Some of the leading companies operating in the global yellow fever treatment market are Panacea Biotech Limited, Themis Bioscience GmbH, Arbovax Inc., and Janssen Pharmaceutcals Inc. Each of the companies is profiled for their attributes of product portfolio, recent developments, and financial standing. GET DISCOUNT ON THE LATEST REPORT TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others. 5-Point Growth Formula The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs. The 5-point growth formula includes the following points: Current and Future Threats Accurate Trend Analysis Regional Assessment Industrial Analogy COVID-19 Impact Current and Future Threats Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats. Accurate Trend Analysis Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues. Regional Assessment Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market. Industrial Analogy The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation. COVID-19 Impact The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly. The reports offer answers to the top 7 questions that revolve around the growth of the market What are the diverse growth parameters influencing the market? Which regions will contribute largely to the growth of the market What are the recent innovations and technological advancements in the market? What are the emerging trends across the market? How has COVID-19 affected the market? What will be the post-pandemic scenario of the market? What are the major threats that will dent the growth prospects of the market? About TMR Research TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends. Contact: Rohit Bhisey TMR Research, 3739 Balboa St # 1097, San Francisco, CA 94121 United States Tel: +1-415-520-1050 Visit Site: